Intellia Therapeutics vs Mammoth Biosciences

Intellia Therapeutics vs Mammoth Biosciences, compared side by side on 20 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Intellia Therapeutics is on 40/100 and Mammoth Biosciences on 63/100.

Intellia Therapeutics logo
Intellia TherapeuticsA clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.
Try Intellia Therapeutics
Mammoth Biosciences logo
Mammoth BiosciencesBiotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.
Try Mammoth Biosciences

Where each one leads

Intellia Therapeutics

  • agent readiness: 42/100 against 35/100
  • domain rating: 60/100 against 53/100

Mammoth Biosciences

  • our overall score: 63/100 against 40/100
  • funding raised: $460M against $310M

At a glance

MeasureIntellia TherapeuticsMammoth Biosciences
What it isA clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.
CategoryBiotech, MedTech, Genomics, Drug DiscoveryBiotechnology, Drug Discovery, Genomics, CRISPR Technology
Sells toBusiness modelB2BB2B
OfferingPlatformPlatform
Founded20142017
HeadquartersCambridge, United StatesBrisbane, United States
StatusActiveActive

Size, funding and growth

MeasureIntellia TherapeuticsMammoth Biosciences
EmployeesNot published165
Headcount growthLast 12 monthsNot published+5.8%
Total funding$310M$460M
Latest roundSeries CFunding Round
ValuationNot published$1.1B
LinkedIn followers71,64057,986

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureIntellia TherapeuticsMammoth Biosciences
StartupHub scoreOur 0-100 rating40/10063/100
Traction40/10060/100
Team70/10070/100
Search visibility31/10035/100
Quality35/10068/100
Agent readinessHow well an AI agent can read and act on the siteD (42/100)F (35/100)
Domain ratingLink authority, 0-10060/10053/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureIntellia TherapeuticsMammoth Biosciences
CDNCloudflareNot detected
CMSWordPressWordPress
FrameworksJqueryJquery
AnalyticsGoogle Analytics 4, Hotjar, FathomGoogle Analytics 4

Intellia Therapeutics vs Mammoth Biosciences: common questions

Which is better, Intellia Therapeutics or Mammoth Biosciences?

On our 0-100 score Mammoth Biosciences rates higher (63/100 against 40/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 20 data points above: read the rows that match what you are buying for.

How do Intellia Therapeutics and Mammoth Biosciences compare on the numbers?

Intellia Therapeutics leads on agent readiness (42/100 against 35/100), domain rating (60/100 against 53/100). Mammoth Biosciences leads on our overall score (63/100 against 40/100), funding raised ($460M against $310M).

Read the full Intellia Therapeutics review and pricing or the Mammoth Biosciences review and pricing. You can also browse other Intellia Therapeutics alternatives we track.